Tag

Sanjiv Goyal

2 articles

Nectar Lifesciences Major Restructuring with ₹12.5B Asset Sales

Nectar Lifesciences completed slump sale of pharmaceutical businesses for ₹12.54B to Ceph Lifesciences, resulting in ₹1.63B exceptional gain but FY26 net loss of ₹2.93B. Company executed ₹810M share b

Nectar Lifesciences 31st AGM Notice September 2026

Nectar Lifesciences convenes 31st AGM on September 18, 2026 via video conference to approve financial statements and director appointments. Remote e-voting available from September 15-17, 2026 with cu